Updated
Updated · University of California San Diego · Jul 16
ReefHaven Ventures Backs 3 UC San Diego MedTech Startups, Targets 24 More Investments
Updated
Updated · University of California San Diego · Jul 16

ReefHaven Ventures Backs 3 UC San Diego MedTech Startups, Targets 24 More Investments

2 articles · Updated · University of California San Diego · Jul 16

Summary

  • Garrett Smith has launched ReefHaven Ventures, a San Diego-focused early-stage medtech fund that has already invested in three UC San Diego-affiliated companies: KatoMed, Acurion and Dragon Vascular.
  • The fund is aimed at filling a local early-stage capital gap, with Smith focusing on startups where medical technology intersects with AI and robotics and where clinical impact is clear.
  • ReefHaven plans more than two dozen San Diego medtech investments over the next few years and is partnering with UC San Diego through weekly office hours for faculty, students, clinicians and founders.
  • UC San Diego says it has launched more than 800 companies, about 60% in life sciences, underscoring the scale of the ecosystem ReefHaven is trying to deepen.

Insights

Can a hyper-local fund turn a regional hub like San Diego into a dominant global leader in medical technology?
As AI threatens to raise healthcare costs short-term, how will new medtech startups prove their economic value to hospitals?
Facing the FDA's 'regulatory doom-loop,' what is the new playbook for getting AI-powered medical devices to market?